Terminal Harvest Procedure of a Large Animal Model of Chronic Myocardial Ischemia with Hemodynamic Characterization and Perfusion Analysis.

J Vis Exp

Department of Surgery, Division of Cardiothoracic Surgery, Warren Alpert Medical School, Brown University; Cardiovascular Research Center, Rhode Island Hospital.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Reproducibility and research integrity are foundational tenets to scientific discovery, which are produced utilizing well-established, proven principles and protocols. Furthermore, with the ever-increasing prevalence and burden cardiovascular disease (CVD) places on individuals and society at large, it deems essential to cultivate robust and validated model for investigation. Our group utilizes a two-surgery protocol in a swine model that has been progressively refined over the last twenty years, in which we first induce chronic myocardial ischemia by placement of an ameroid constrictor mimicking the pathophysiology of coronary artery disease (CAD) in humans. The second and terminal procedure is a comprehensive and thoughtful collection of cardiac hemodynamic parameters as well as regional coronary perfusion, followed by beating heart euthanasia and detailed sectioning of the heart. Our lab uses isotope-labeled microspheres to analyze myocardial blood flow to the ischemic area as a powerful method to quantify collateralization due to experimental therapeutic agents. Furthermore, and likely the most important measurable cardiovascular outcome, we utilize left ventricular pressure-volume (PV) loop catheterization to measure a broad range of hemodynamic parameters. We hope by detailing the comprehensive cardiac analysis of our swine model of chronic myocardial ischemia, other researchers may improve and cultivate their own protocols and therapy investigation for the elimination of cardiovascular disease.

Download full-text PDF

Source
http://dx.doi.org/10.3791/68545DOI Listing

Publication Analysis

Top Keywords

chronic myocardial
12
myocardial ischemia
12
model chronic
8
cardiovascular disease
8
swine model
8
hemodynamic parameters
8
terminal harvest
4
harvest procedure
4
procedure large
4
large animal
4

Similar Publications

Objective: To compare postoperative outcomes between combined fascia iliaca compartment-sciatic nerve blockade (FICB-SNB) and monitored anesthesia care (MAC) in patients with chronic limb-threatening ischemia (CLTI) undergoing lower-extremity revascularization (LER).

Design: Retrospective matched cohort study (1:1 propensity score matching).

Setting: Single-center analysis of CLTI patients undergoing LER.

View Article and Find Full Text PDF

Effect of an integrated care model on ST-segment elevation myocardial infarction management in China: a prospective, multicentre, non-randomised controlled study.

Heart

September 2025

Department of Cardiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.

Background: Early reperfusion therapy is critical in patients with ST-segment elevation myocardial infarction (STEMI). However, limitations in resources and patient-level and system-level barriers delay the administration of reperfusion therapy. This study evaluated the impact of an integrated care strategy for STEMI management in China.

View Article and Find Full Text PDF

Objective: The impact of off-label underdosing of direct oral anticoagulants (DOACs) on clinical outcomes in patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) remains unclear.

Methods: The EPIC-CAD trial (Edoxaban vs Edoxaban with antiPlatelet agent In patients with atrial fibrillation and Chronic stable Coronary Artery Disease) randomised patients with AF and stable CAD to receive either edoxaban monotherapy or dual antithrombotic therapy (edoxaban plus single antiplatelet agent). Off-label underdosing was defined as low-dose edoxaban (30 mg once daily) without standard criteria for dose reduction.

View Article and Find Full Text PDF

Background: Balancing the risks of thrombotic and bleeding events in people with advanced kidney disease is a clinical challenge.

Objectives: To estimate rates of major adverse thrombotic events (MATEs) and bleeding events in individuals with chronic kidney disease (CKD) stages 4 or 5 or with end-stage kidney disease (ESKD) receiving hemodialysis (HD) or peritoneal dialysis (PD).

Methods: Using administrative claims from a 20% Medicare sample, Optum's de-identified Clinformatics Data Mart Database, and the US Renal Data System from 2016-2019, we identified individuals with CKD stages 4 or 5 and individuals with dialysis-dependent ESKD.

View Article and Find Full Text PDF

Objective: Aim: To evaluate the state of oxidation processes and morphological changes in the heart of rats with chronic hypodynamia during the development of epinephrine heart damage (EHD)..

Patients And Methods: Materials and Methods: The study was performed on 144 white male Wistar rats.

View Article and Find Full Text PDF